SPN003/SPN004

N/A

Report date: 2023/02/21 17:54:27
NME

Base Information

Drug NameSPN003/SPN004
Drug Alias NameSPN003SPN004
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesSinopep Allsino Bio Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSinopep Allsino Bio Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A